A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Clinical trial NCT05929235 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05929235
- Sponsor
- Flare Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2027-10-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.